Beldio Research GmbH
Memmingen, Germany
Research institute in Memmingen, Bavaria
Kramerstraße 15, 87700 Memmingen
About Beldio Research GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Incyte Corporation
2
RHEACELL GmbH & Co. KG
1
Clinical Trials at Beldio Research GmbH
During the past decade, Beldio Research GmbH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
2021-08-18
2023-08-01
Recruiting
200
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
2023-01-31
2024-09-22
Withdrawn
0
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
2023-01-31
2024-09-22
Withdrawn
0
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Beldio Research GmbH"
#1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator and "Ticeba GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Beldio Research GmbH
According to Clinical.Site data, the most researched conditions in "Beldio Research GmbH" are
"Chronic Hand Eczema (CHE)" (1 trials), "Hand Eczema" (1 trials) and "Skin Ulcer Venous Stasis Chronic" (1 trials). Many other conditions were trialed in "Beldio Research GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Beldio Research GmbH
Most popular intervention types in "Beldio Research GmbH" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ruxolitinib cream" (2 trials), "Vehicle" (2 trials), "Placebo" (1 trials) and "allo-APZ2-CVU" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Beldio Research GmbH
The vast majority of trials in "Beldio Research GmbH" are
3 trials for "All" genders.
Clinical Trials Status at Beldio Research GmbH
Currently, there are NaN active trials in "Beldio Research GmbH".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Beldio Research GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Beldio Research GmbH, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".